Accelerates Solventum's business transformation and sharpens focus on strategic areas for growth to deliver long-term shareholder value Strengthens balance sheet with proceeds to be used primarily for debt paydown ST. PAUL, Minn., Feb. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration1 business to Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") for $4.1 billion. Solventum expects the transaction to b ...